BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu JJ. Use of corticosteroids during acute phase of Kawasaki disease. World J Clin Pediatr 2015; 4(4): 135-142 [PMID: 26566486 DOI: 10.5409/wjcp.v4.i4.135]
URL: https://www.wjgnet.com/2219-2808/full/v4/i4/135.htm
Number Citing Articles
1
Yudha Fadhol Arafah, Sasmito Nugroho, Noormanto Noormanto, Nadya Arafuri, Indah Kartika Murni. Methylprednisolone as an alternative therapy for Kawasaki disease: case seriesPaediatrica Indonesiana 2020; 60(5): 283 doi: 10.14238/pi60.5.2020.283-6
2
Dima Chbeir, Jean Gaschignard, Ronan Bonnefoy, Constance Beyler, Isabelle Melki, Albert Faye, Ulrich Meinzer. Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesionsPediatric Rheumatology 2018; 16(1) doi: 10.1186/s12969-018-0264-7
3
James E. Fitzpatrick, Whitney A. High, W. Lamar Kyle. Urgent Care Dermatology: Symptom-Based Diagnosis2018; : 51 doi: 10.1016/B978-0-323-48553-1.00004-5
4
Euri Seo, Jeong Jin Yu, Hyun Ok Jun, Eun Jung Shin, Jae Suk Baek, Young-Hwue Kim, Jae-Kon Ko. Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatmentKorean Journal of Pediatrics 2016; 59(10): 408 doi: 10.3345/kjp.2016.59.10.408
5
Yazdan Rahmati, Hasan Mollanoori, Naser Kakavandi, Alireza Nateghian, Shirin Sayyahfar, Vahid Babaei, Sajad Esmaeili, Shahram Teimourian. Gene expression analysis in Kawasaki disease; bioinformatics and experimental approachInformatics in Medicine Unlocked 2020; 20: 100423 doi: 10.1016/j.imu.2020.100423
6
Vijayakumary Thadchanamoorthy, Kavinda Dayasiri. Refractory Kawasaki Disease Presenting With Erythema at Bacille Calmette-Guérin Inoculation Site: A Paediatric Case ReportCureus 2020;  doi: 10.7759/cureus.10928
7
菊红 吕. Progress in Clinical Treatment of Kawasaki Disease at Home and AbroadAdvances in Clinical Medicine 2019; 9(08): 889 doi: 10.12677/ACM.2019.98137
8
Shreya Agarwal, Devendra K. Agrawal. Kawasaki disease: etiopathogenesis and novel treatment strategiesExpert Review of Clinical Immunology 2017; 13(3): 247 doi: 10.1080/1744666X.2017.1232165
9
Victoria J. Wright, Jethro A. Herberg, Myrsini Kaforou, Chisato Shimizu, Hariklia Eleftherohorinou, Hannah Shailes, Anouk M. Barendregt, Stephanie Menikou, Stuart Gormley, Maurice Berk, Long Truong Hoang, Adriana H. Tremoulet, John T. Kanegaye, Lachlan J. M. Coin, Mary P. Glodé, Martin Hibberd, Taco W. Kuijpers, Clive J. Hoggart, Jane C. Burns, Michael Levin. Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression SignatureJAMA Pediatrics 2018; 172(10): e182293 doi: 10.1001/jamapediatrics.2018.2293
10
Ronghao Zheng, Jing Xie, Weijie Li, Jianping Shang, Zuliang Shi, Songbai Zhu, Lin Gui, Li Huang, Lan Shu, Donglei Liu, Yi Gong, Xiaohui Li, Wanxia Chai, Xiaofen Huang, Xiaolin Wu, Jing Yue. MiR‐223‐3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3Immunity, Inflammation and Disease 2023; 11(7) doi: 10.1002/iid3.939
11
Ling-Sai Chang, Ho-Chang Kuo. The role of corticosteroids in the treatment of Kawasaki diseaseExpert Review of Anti-infective Therapy 2020; 18(2): 155 doi: 10.1080/14787210.2020.1713752
12
Massimo Gallerani, Marco Pala, Fabio Fabbian, Alfredo De Giorgi. Acute cholestasis as uncommon onset of Kawasaki disease: a case reportBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01495-6